SuperworthLipocine market cap LPCN
Share price times shares outstanding: what the whole company sells for, since 2013.
- Today, Oct 23, 2026
- $11.9M
- Highest close in our data
- $329.1M
- Sep 2015
Lipocine is worth $11.9M at the close on Oct 23, 2026, at $1.44 a share.
That is down 24% over the last year and down 87% over five years.
Its highest close in our data was $329.1M in Sep 2015.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $11.9M | $11.9M | $61.8M | −59% |
| 2025 | $29M | $14.1M | $29M | +14% |
| 2024 | $25.5M | $15.4M | $50.8M | +72% |
| 2023 | $14.8M | $12.7M | $49.2M | −58% |
| 2022 | $35.2M | $33.7M | $163.3M | −60% |
| 2021 | $87.5M | $87.5M | $147.4M | −2% |
| 2020 | $89.3M | $10.4M | $140.3M | +890% |
| 2019 | $9M | $8.6M | $80M | −61% |
| 2018 | $23M | $23M | $64.2M | −69% |
| 2017 | $72.9M | $61.5M | $101.3M | +9% |
| 2016 | $67.2M | $55.5M | $225.1M | −72% |
| 2015 | $236M | $66.9M | $329.1M | +258% |
| 2014 | $66M | $50.5M | $123.3M | −28% |
| 2013 | $91.8M | $35M | $99M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Lipocine's size, closest first, today.
| Company | Market cap |
|---|---|
| LPCNLipocine | $11.9M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Lipocine
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.